Technology | Ultrasound Imaging | December 14, 2016

Clarius Wireless Ultrasound Receives FDA 510(k) Clearance

C3 and L7 models are compatible with the latest iOS and Android smartphones and tablets

Clarius Mobile Health, C3, L7, wireless ultrasound scanners, FDA 510k clearance

December 14, 2016 — Clarius Mobile Health announced the U.S. Food and Drug Administration (FDA) has cleared the C3 and L7 Clarius Wireless Ultrasound Scanners, which are compatible with the latest iOS and Android smartphones and tablets.

"Clarius is the future of patient care. The image quality is amazing for any scanner, much less one that fits in my pocket," said Steven Steinhubl, M.D., director of digital medicine at the Scripps Translational Science Institute.  "The ability to wirelessly connect it to any Apple or Android device means that anyone on my team can use it with whatever they already carry around in their pocket."

Introduced in March 2016, Clarius Ultrasound Scanners are intended for clinicians to conduct quick scans and to guide short procedures at the bedside. The Clarius C3 multipurpose ultrasound scanner is designed to image the abdomen and lungs; it also incorporates a virtual phased array for quick scans of the heart. The Clarius L7 is ideal for guiding procedures and imaging superficial structures.

Unlike other app-based ultrasound systems that draw power from a connected smart device, Clarius Scanners are powered by a rechargeable battery, which is easily exchanged when running low. Two batteries and a charger are delivered with each scanner. Built with a magnesium case, the devices are designed to withstand challenging environments and are water submersible for easy cleaning and disinfection.

"Having used Clarius in an educational setting, I am excited about its potential to put ultrasound into the hands of more clinicians," said Thomas Cook, M.D., of 3rd Rock Ultrasound. "Besides being portable and easy to use, I'm very impressed by the image quality produced by such a compact ultrasound machine."

As a direct-to-professionals e-commerce company, Clarius aims to make ultrasound systems affordable and easily accessible to medical professionals. To facilitate online sales, the company offers customers the ability to return the product after a one-week trial period for a small handling fee. The company's e-commerce portal is supported by a telesales team.  Clarius Scanners are also available from a network of sales partners across the country.

For more information: www.clarius.me

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Sponsored Content | Videos | Ultrasound Imaging | January 06, 2020
The Arietta 850SE provides facilities with numerous features and functionality to get the most out of a system.
The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fufifilm capture a parger portion of international radiology market share. Photo by Dave Fornell.

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fujifilm capture a larger portion of international radiology market share. Photo by Dave Fornell.

Feature | Radiology Business | December 17, 2019 | Dave Fornell, Editor
December 17, 2019 — It was disclosed today that Fujifilm may buy Hitachi's diagnostic imaging business in a deal that
MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier